On Monday, 15 February 2021, the World Trade Organization’s General Council, “agreed by consensus to select Ngozi Okonjo-Iweala of Nigeria as the organization’s seventh Director-General” (Source: History is made: Ngozi Okonjo-Iweala chosen as Director-General, 15 February 2021). Dr Ngozi is… Continue Reading
(More on the USTR Special 301. link) Attached are links to several of the industry submissions for the 2021 USTR Special 301 list. The Docket: USTR-2020-0041 PhRMA 2021 Special 301 Review Comment, and Correction to Comment BIO 2021 Special 301… Continue Reading
On February 9, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Cell Therapies for Cancer” to Ziopharm Oncology, Inc. (Ziopharm). The… Continue Reading
On Tuesday February 9, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Certain Fusion Proteins and Their Use for the Treatment… Continue Reading
KEI has created a public listserve to discuss vaccine manufacturing scale up. (link) February 19, 2021: Roundtable on Pathways to Scale Up Manufacturing Capacity for COVID-19 Vaccines – 19. KEI has gathered data regarding vaccine manufacturing capacity in countries worldwide,… Continue Reading
KEI roundtable on pathways to scale up manufacturing capacity for COVID-19 vaccines Friday, 19 February 2021 14h00 UTC to 16h00 UTC 15h00 CET to 17h00 CET 09h00 EST to 11h00 EST On Friday, 19 February 2021, KEI will host a… Continue Reading
KEI has reviewed an exclusive license between the National Institute of Allergy and Infectious Diseases (NIAID) and AbCellera Biologics (“AbCellera”) concerning a technology invented by NIAID that apparently is being used for the Eli Lilly (“Lilly”) antibody treatment for COVID-19… Continue Reading
One of the main objections to march-in rights and reasonable pricing clauses is the repeated assertion by NIH leadership that pharmaceutical companies would never agree to a partnership with the federal government that involves price constraints. This argument defies logic… Continue Reading
On Tuesday, 26 January 2021, Dr. Ursula von der Leyen, President of the European Commission delivered a special address at “Davos Agenda Week” devoting much of her speech to the European Union’s response to the COVID-19 pandemic. While President von… Continue Reading